Financhill
Back

Terns Pharmaceuticals Quote, Financials, Valuation and Earnings

Terns Pharmaceuticals Price Quote

$5.89
+0.10 (+1.73%)
(Updated: November 26, 2024 at 5:55 PM ET)

Terns Pharmaceuticals Key Stats

Sell
44
Terns Pharmaceuticals (TERN) is a Sell

Day range:
$5.71 - $5.96
52-week range:
$3.68 - $11.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.35%

Volume:
1M
Avg. volume:
1.3M
1-year change:
47.7%
Market cap:
$491.8M
Revenue:
$0
EPS:
$-1.18

How Much Does Terns Pharmaceuticals Make?

Data Unavailable

Is Terns Pharmaceuticals Growing As A Company?

Data Unavailable

Terns Pharmaceuticals Stock Price Performance

What Is Terns Pharmaceuticals 52-Week High & Low?

Terns Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Terns Pharmaceuticals?

Is Terns Pharmaceuticals Cash Flow Positive?

  • What Is TERN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$74.7M
  • What Is Terns Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $177.6M
  • What Is Terns Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $129.2M

Terns Pharmaceuticals Return On Invested Capital

Data Unavailable

Terns Pharmaceuticals Earnings Date & Stock Price

Terns Pharmaceuticals Competitors

Terns Pharmaceuticals Dividend Yield

Terns Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 12.91%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 18.19
Upside from Last Price: 214.12%

Major Shareholders

  • How many TERN shares are owned by institutional investors?
    109.8M TERN shares are owned by institutional investors
  • How many TERN shares are owned by insiders?
    628.1K TERN shares are owned by insiders